SOLVED1673

Could the conduct of Insys alleged by the Department of Justice lead to patient harm? Group of answer choices No because the patients who received Subsys had pain, according to the doctor who prescribed the medicine. Yes, because most prescriptions appear to be for off-label use, and those receiving the prescriptions off-label could potentially become addicted to Subsys, negatively contributing to the opioid abuse epidemic in the U.S. Yes, because many patients who received Subsys were not suffering from breakthrough cancer pain – therefore, no clinical trials had been conducted to assess the efficacy and safety in those off-label patient populations. Yes, because evidence and guilty pleas demonstrate that many prescriptions were induced by money, thus clouding the independent clinical judgment of the prescribing physician – many if not all of those patients could experience unnecessary side effects or become addicted. B, C, and D.
SCIENCE
HEALTH SCIENCE
NURSING

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."